Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Marinus Pharmaceuticals, Inc. (MRNS)

« Back to company index

MRNS Chatter Timeline

Stock Ticker for MRNS

Most Active Tweeters for MRNS

UserTweets
@MysteriousMole1 16
@FlashAlert_me 11
@_B_I_O_T_E_C_H_ 9
@InsiderAlerts4U 6
@Tickeron 4

Recent Tweets for MRNS

TradingAloha @TradingAloha
#idea $MRNS The move is getting close. High compression squeeze with momentum trending upward. Looking for a fast p… https://t.co/MxVMGWZ0UG
January 20th 2021, 5:01am
InsiderAlerts4U @InsiderAlerts4U
$MRNS: New Insider Filing on MARINUS PHARMACEUTICALS INC's Director CHARLES AUSTIN: https://t.co/2oXgd228QR
January 20th 2021, 5:01am
InsiderAlerts4U @InsiderAlerts4U
$MRNS: New Insider Filing on MARINUS PHARMACEUTICALS INC's Director ELAN EZICKSON: https://t.co/2FH4iYGeRt
January 20th 2021, 4:01am
InsiderAlerts4U @InsiderAlerts4U
$MRNS: New Insider Filing on MARINUS PHARMACEUTICALS INC's Chief Medical Officer JOSEPH HULIHAN: https://t.co/x0ssHO4PP2
January 20th 2021, 4:01am
InsiderAlerts4U @InsiderAlerts4U
$MRNS: New Insider Filing on MARINUS PHARMACEUTICALS INC's VP Gen Counsel and Corp Sec. MARTHA E MANNING: https://t.co/GeoOhSkfGb
January 20th 2021, 3:01am
InsiderAlerts4U @InsiderAlerts4U
$MRNS: New Insider Filing on MARINUS PHARMACEUTICALS INC's Chief Executive Officer SCOTT BRAUNSTEIN: https://t.co/tFsOZpKUIB
January 20th 2021, 3:01am
InsiderAlerts4U @InsiderAlerts4U
$MRNS: New Insider Filing on MARINUS PHARMACEUTICALS INC's Director ENRIQUE J. CARRAZANA: https://t.co/FKVetpiiZM
January 20th 2021, 1:01am
StockTexts @StockTexts
$MRNS Marinus Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/TyBRU4asIe
January 20th 2021, 1:01am
FlashAlert_me @FlashAlert_me
$MRNS [15s. delayed] filed SEC form 4: Director DOUGHERTY MICHAEL R: Transacted Derivative Securities on 2021-01-1… https://t.co/2byRISa3zQ
January 20th 2021, 1:01am
FlashAlert_me @FlashAlert_me
$MRNS [15s. delayed] filed SEC form 4: Director Carrazana Enrique J.: Transacted Derivative Securities on 2021-01-… https://t.co/qrJ6Pj7bdZ
January 20th 2021, 1:01am
FlashAlert_me @FlashAlert_me
$MRNS [15s. delayed] filed SEC form 4: Chief Executive Officer Braunstein Scott: Transacted Derivative Securities… https://t.co/V2l5S6OdQJ
January 20th 2021, 1:01am
FlashAlert_me @FlashAlert_me
$MRNS [15s. delayed] filed SEC form 4: Director Austin Charles: Transacted Derivative Securities on 2021-01-15. https://t.co/YoFvqots65
January 20th 2021, 1:01am
FlashAlert_me @FlashAlert_me
$MRNS [15s. delayed] filed SEC form 4: Director Ezickson Elan: Transacted Derivative Securities on 2021-01-15. https://t.co/M58ilGotyS
January 20th 2021, 1:01am
StockTexts @StockTexts
$MRNS Marinus Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/cTQKOZm6OR
January 20th 2021, 1:01am
FlashAlert_me @FlashAlert_me
$MRNS [15s. delayed] filed SEC form 4: Director Fischer Seth H. Z.: Transacted Derivative Securities on 2021-01-15… https://t.co/plvIwhM8fk
January 20th 2021, 1:01am
FlashAlert_me @FlashAlert_me
$MRNS [15s. delayed] filed SEC form 4: Chief Medical Officer Hulihan Joseph: Transacted Derivative Securities on 2… https://t.co/GWaLQ7bpAG
January 20th 2021, 1:01am
FlashAlert_me @FlashAlert_me
$MRNS [15s. delayed] filed SEC form 4: VP Gen Counsel and Corp Sec. MANNING MARTHA E: Transacted Derivative Securi… https://t.co/nT2dfRSztp
January 20th 2021, 1:01am
FlashAlert_me @FlashAlert_me
$MRNS [15s. delayed] filed SEC form 4: Director MAYLEBEN TIMOTHY M: Transacted Derivative Securities on 2021-01-15… https://t.co/Rn9lz8dkpn
January 20th 2021, 1:01am
intratio @intratio
$MRNS https://t.co/OUo56XurEF Marinus Pharmaceuticals Inc Our advanced model is predicting that this companie s sto… https://t.co/aouA6I6Dad
January 19th 2021, 3:01am
QuantchaIdeas @QuantchaIdeas
StockTwits Trending Alert: Trading recent interest in MARINUS PHARMACEUTICALS INC. $MRNS https://t.co/vka4Qqu4Gh
January 16th 2021, 4:01pm
SwingTradeBot @SwingTradeBot
Recent $MRNS technical alerts: Non-ADX 1,2,3,4 Bearish plus 9 more alerts... https://t.co/lrDrafI7sh
January 16th 2021, 4:01pm
ML_Tweet_Bot @ML_Tweet_Bot
RT @intratio: $MRNS https://t.co/OUo56XurEF Marinus Pharmaceuticals Inc The machine learning model concludes this equity value will go sout…
January 15th 2021, 11:01pm
intratio @intratio
$MRNS https://t.co/OUo56XurEF Marinus Pharmaceuticals Inc The machine learning model concludes this equity value wi… https://t.co/24a9awy8EL
January 15th 2021, 11:01pm
aaadhikari @aaadhikari
Added $MRNS 12.6
January 15th 2021, 3:01pm
RolandoAMoreno @RolandoAMoreno
RT @MysteriousMole1: $MRNS at JPM: literature suggests +/- 10% likelihood of response to additional AED in the patients enrolled in the PhI…
January 15th 2021, 12:01am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @MysteriousMole1: $MRNS Q&A cntd: - physician interactions at AED: success in CDD, which is extremely refractory, stokes interest to run…
January 14th 2021, 10:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @MysteriousMole1: $MRNS Q&A cntd: - On BARDA partnership: agency interested in intramuscular formulation of GNX for use in the battlefie…
January 14th 2021, 9:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @MysteriousMole1: $MRNS Q&A cntd: - Q on IV franchise, A: physician enthusiasm helps get the PhIII in RSE off the ground despite the pan…
January 14th 2021, 9:01pm
MysteriousMole1 @MysteriousMole1
$MRNS Q&A cntd: - physician interactions at AED: success in CDD, which is extremely refractory, stokes interest to… https://t.co/QI2x6GRcVR
January 14th 2021, 9:01pm
MysteriousMole1 @MysteriousMole1
$MRNS Q&A cntd: - based on strategic discussions, expect to add to balance sheet in non-dilutive way by mid-2021 -… https://t.co/gd2IwcMw6s
January 14th 2021, 9:01pm
MysteriousMole1 @MysteriousMole1
$MRNS Q&A cntd: - On BARDA partnership: agency interested in intramuscular formulation of GNX for use in the battle… https://t.co/88pofPVnnW
January 14th 2021, 9:01pm
MysteriousMole1 @MysteriousMole1
$MRNS Q&A cntd: - Q on IV franchise, A: physician enthusiasm helps get the PhIII in RSE off the ground despite the… https://t.co/SC2vAwp3Yw
January 14th 2021, 9:01pm
MysteriousMole1 @MysteriousMole1
$MRNS Q&A: - on NDA submission: FDA confirmation of sufficiency of single PhIII trial addresses key concern of both… https://t.co/dsCA4tdQ3c
January 14th 2021, 9:01pm
MysteriousMole1 @MysteriousMole1
$MRNS - On PCDH19: episodic cluster seizures; ongoing double-blind study to deliver top-line data before end of Q1 (!!!)
January 14th 2021, 9:01pm
MysteriousMole1 @MysteriousMole1
$MRNS - given that TSC trial replicates CDD PhIII TID dosing, and presents with similar allo-s disruption, Co is co… https://t.co/XX6YLuOnSx
January 14th 2021, 9:01pm
MysteriousMole1 @MysteriousMole1
$MRNS - next gen formulations will open up large swathes of new applications beyond refractory epilepsy - on the o… https://t.co/bO0bEhs7UF
January 14th 2021, 8:01pm
MysteriousMole1 @MysteriousMole1
$MRNS future of the franchise: - when dosed TID in CDD, 70% of patients had excellent absorption of GNX - Co worki… https://t.co/Jklr3qMKy6
January 14th 2021, 8:01pm
MysteriousMole1 @MysteriousMole1
$MRNS despite frailty of CDD patients, oral GNX exhibited no new safety signals - very clean drug Duration of effi… https://t.co/yJPEdwbhYw
January 14th 2021, 8:01pm
MysteriousMole1 @MysteriousMole1
$MRNS recap of CDD prevalence and results of 1st ever, global PhIII (n=100) which achieved primary endpoint with hi… https://t.co/dtGlBVqMGv
January 14th 2021, 8:01pm
MysteriousMole1 @MysteriousMole1
$MRNS at JPM: literature suggests +/- 10% likelihood of response to additional AED in the patients enrolled in the… https://t.co/jTGBoddt4F
January 14th 2021, 8:01pm
DuarteSatirico @DuarteSatirico
RT @semodough: CANT $MRNS PT $27 FDA gave positive response on filing of an NDA based on one Ph3 trial in CDKL5 deficiency disorder (CDD),…
January 14th 2021, 12:01pm
semodough @semodough
CANT $MRNS PT $27 FDA gave positive response on filing of an NDA based on one Ph3 trial in CDKL5 deficiency disorde… https://t.co/b5oP1mFETc
January 14th 2021, 12:01pm
rmacmillan310 @rmacmillan310
$MRNS price movement 11.04 % https://t.co/aELNYugChp
January 14th 2021, 8:01am
BioWino @BioWino
$mrns $kura.. complete clownshow after they offered those names. banks are just giving stock to anyone apparently
January 14th 2021, 1:01am
MaisaCorp @MaisaCorp
$MRNS FDA supporting the filing of a new drug application for the use of the company's oral ganaxolone drug candida… https://t.co/GOvi5VYjVo
January 13th 2021, 9:01pm
MysteriousMole1 @MysteriousMole1
RT @semodough: Baird $MRNS Key catalyst In 1H21, mgt readout top-line data from Phase 2 Violet study oral ganaxolone in PCDH19-related epi…
January 13th 2021, 9:01pm
StockNewsNow @StockNewsNow
$MRNS Marinus Pharmaceuticals Receives Positive Response from FDA on Sufficiency of One Phase 3 Clinical Trial for… https://t.co/YU4jFeWij1
January 13th 2021, 8:01pm
semodough @semodough
Baird $MRNS Key catalyst In 1H21, mgt readout top-line data from Phase 2 Violet study oral ganaxolone in PCDH19-re… https://t.co/jcmSPij3G6
January 13th 2021, 7:01pm
InvestrClouseau @InvestrClouseau
RT @_B_I_O_T_E_C_H_: $MRNS Marinus Pharmaceuticals Receives Positive Response From #FDA On Sufficiency Of One Phase 3 Clinical Trial For Fi…
January 13th 2021, 3:01pm
MarcJacksonLA @MarcJacksonLA
$MRNS Marinus Pharmaceuticals Receives Positive Response from FDA on Sufficiency of One Phase 3 Clinical Trial for… https://t.co/GOPqfIfsv2
January 13th 2021, 3:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.